Pfizer Inc. news

   Watch this stock
Showing stories 1 - 10 of about 67   

Articles published

PFE 31.15 +0.05 (0.16%)
price chart
FDA Recommendations Bode Well For Pfizer
Pfizer (NYSE:PFE) is still transitioning itself after its best selling drug Lipitor went off patent in 2011. Also starting in July a marketing partnership between Amgen and Pfizer ends which will result in a large loss of revenue from the blockbuster ...
Pfizer Gets Support For Arthritis Drug Approval  ValueWalk
FDA staff question Pfizer arthritis drug benefits  Reuters
Related articles »  
Pfizer: Why Now Is The Best Time To Buy
The days of Pfizer dominating the industry with one or two products has passed; the key to its success now is to have a stake and influence in a variety of treatments that are specifically targeted for certain high margin ailments or segments of the ...
Pfizer Launches Lipitor Mobile App  MediaPost Communications
Pfizer offers Lipitor app as generics hit market  mobihealthnews
Related articles »  
Pfizer Could Plummet Without Lipitor Replacement
Pfizer now will need to adapt in order to remain as profitable as possible now that it has lost the valuable patents for its main drugs.
Related articles »  
Pfizer, Teva Reach Licensing Deal For Generic Zyvox
Law360, New York (May 31, 2012, 4:15 PM ET) -- Pfizer Inc. and Teva Pharmaceutical Industries Ltd. have reached an agreement on a licensing deal for a generic version of Pfizer's antibiotic Zyvox, according to a settlement affirmed by a Delaware ...
Merck, Pfizer Back Lawmakers Who Oppose Company Products
There was plenty of debate about the new health-care law in the 2010 congressional elections while little, if any, on birth control.
Related articles »  
Goodbye, Lipitor. Pfizer Bids a Farewell
But after spending more than $87 million promoting the medicine, the world's biggest drug company is quietly giving up on its once-great cash cow for good because more generic versions will soon be going on sale.
Related articles »  
Fortune 500: Pfizer drops to No. 40 in 2012 rankings
Pfizer sign AP/FILEPfizer came in at No. 40 on the Fortune 500, the only major employer in Southwest Michigan to break the Top 50 of the annual rankings.
Pfizer top pharma firm on Fortune 500  NJBIZ
Related articles »  
Pfizer Names Olivier Brandicourt as President and General Manager, Emerging ...
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) named Olivier Brandicourt as President and General Manager of the Emerging Markets and Established Products Business Units, effective June 1, 2012.
PPD names new CEO
PPD Names David Simmons Chairman and CEO  WWAY NewsChannel 3
Related articles »  
Pfizer: Alzheimer's Drugs Will Carry Stock To New Highs In 2013
There is a strong market for any drug that can mitigate or even delay the effects of Alzheimer's disease, and if Pfizer became the first company with a drug to market for Alzheimer's disease I think the news could bring Pfizer stock to new highs ...
Pfizer Reports Subpar Lyrica Phase 3 Results  dailyRx
Pfizer Says Lyrica Fails in Diabetes Trial, Halts HIV Study  BusinessWeek
Related articles »  
Dow Chemical taking Pfizer space
COLLEGEVILLE �Dow Chemical Co. has finalized a long-term lease on 800,000 square feet of space at Pfizer Inc.'s campus here in what is one of the largest lease deals to be struck in the suburban office market.